Stephen Hahn, MD, is set to become the next FDA commissioner after the Senate voted Dec. 12 to confirm him, STAT reported.
Dr. Hahn, who was nominated by President Donald Trump in September, will become commissioner at a time when the FDA faces bipartisan criticism for failing to stop youth vaping.
He was confirmed by a vote of 72-18.
He will take the reins from Ned Sharpless, MD, who has served as acting commissioner since Scott Gottlieb, MD, resigned in April.
A practicing radiation oncologist, Dr. Hahn was most recently CMO of MD Anderson Cancer Center in Houston.
Read the full article here.
More articles on leadership and management:
Pennsylvania hospital CEO resigns amid financial woes, medical service ban
White House's Dr. Ronny Jackson seeks seat in Congress
Michael Dowling: When it comes to health disparities, gaps in mental health treatment are the worst